Serum inhibitory and bactericidal activity of telavancin in non-infected subjects with severe renal impairment or end-stage renal disease.

Abstract

Telavancin biological activity, determined by serum titers against a reference strain of Staphylococcus aureus, was maintained in the serum of subjects with severe renal impairment or end-stage renal disease suggesting that there is no apparent effect of renal function on in vitro activity of telavancin. 
DOI: 10.1016/j.diagmicrobio.2014.09.002

Topics

Cite this paper

@article{Barriere2014SerumIA, title={Serum inhibitory and bactericidal activity of telavancin in non-infected subjects with severe renal impairment or end-stage renal disease.}, author={Steven L. Barriere and David Farrell and Paul Rhomberg and Ronald Jones}, journal={Diagnostic microbiology and infectious disease}, year={2014}, volume={80 4}, pages={327-9} }